A detailed history of Alyeska Investment Group, L.P. transactions in Insmed Inc stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 747,402 shares of INSM stock, worth $58.6 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
747,402
Previous 428,804 74.3%
Holding current value
$58.6 Million
Previous $28.7 Million 89.91%
% of portfolio
0.3%
Previous 0.17%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$62.0 - $79.01 $19.8 Million - $25.2 Million
318,598 Added 74.3%
747,402 $54.6 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $5.03 Million - $15.9 Million
228,804 Added 114.4%
428,804 $28.7 Million
Q1 2024

May 15, 2024

BUY
$25.72 - $29.94 $5.14 Million - $5.99 Million
200,000 New
200,000 $5.43 Million
Q2 2023

Aug 14, 2023

SELL
$16.44 - $21.1 $1.19 Million - $1.53 Million
-72,516 Reduced 36.26%
127,484 $2.69 Million
Q1 2023

May 15, 2023

BUY
$16.26 - $21.73 $813,000 - $1.09 Million
50,000 Added 33.33%
200,000 $3.41 Million
Q4 2022

Feb 14, 2023

BUY
$16.98 - $23.15 $2.55 Million - $3.47 Million
150,000 New
150,000 $3 Million
Q4 2019

Feb 14, 2020

SELL
$16.12 - $24.98 $2.01 Million - $3.11 Million
-124,654 Reduced 46.44%
143,765 $3.43 Million
Q3 2019

Nov 14, 2019

BUY
$15.49 - $25.78 $1.13 Million - $1.87 Million
72,634 Added 37.1%
268,419 $4.73 Million
Q2 2019

Aug 14, 2019

SELL
$23.0 - $32.19 $4.38 Million - $6.13 Million
-190,587 Reduced 49.33%
195,785 $0
Q2 2018

Aug 14, 2018

SELL
$20.0 - $29.72 $752,900 - $1.12 Million
-37,645 Reduced 8.88%
386,372 $9.14 Million
Q1 2018

May 15, 2018

BUY
$21.69 - $32.99 $2.4 Million - $3.64 Million
110,480 Added 35.24%
424,017 $9.55 Million
Q4 2017

Feb 14, 2018

BUY
$26.43 - $31.78 $487,342 - $585,991
18,439 Added 6.25%
313,537 $9.78 Million
Q3 2017

Nov 14, 2017

BUY
$11.61 - $31.21 $3.43 Million - $9.21 Million
295,098
295,098 $9.21 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.6B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.